ArticleJMA journal2026
High-Cost Medical Expense Benefit System in Japanese Universal Health Coverage.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the citizens of Japan have universal health coverage, the out-of-pocket expenses can still be exorbitant. In 1973, the High-Cost Medical Expense Benefit System was implemented to reduce this financial strain. The system was initially reimbursement based and later evolved into an in-kind benefit model, reducing upfront payments through prior applications or Individual Number Card use. The system permits expenses to be combined among household members; when several high costs have accrued, future monthly ceilings are reduced. Special provisions apply to chronic conditions such as dialysis and hemophilia. In 2024, a governmental proposal to raise the monthly ceiling of the High-Cost Medical Expense Benefit System, which was established to prevent individuals from incurring catastrophic health expenditures, faced criticism for excluding patient feedback. The government subsequently withdrew the proposal and formed a committee to discuss future reforms focusing on sustainability, intergenerational equity, and effective benefit delivery. The High-Cost Medical Expense Benefit System remains essential for ensuring access to advanced care without compromising patients' daily lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.